Maham Fatima
Sun, February 8, 2026 astatine 11:18 AM CST 2 min read
On January 7, Stifel raised its terms people for Solventum to $105 from $88 and maintained a Buy rating. The steadfast believes that the outlook for large-cap MedTech successful 2026 is favorable pursuing the pressures faced successful 2025.
On December 23, Solventum Corporation (NYSE:SOLV) finalized its acquisition of Acera Surgical, which is simply a bioscience institution that specializes successful synthetic insubstantial matrices for regenerative coiled care, for an upfront currency outgo of $725 million. The deal, which includes up to $125 cardinal successful further milestone-based payments, is designed to heighten Solventum’s MedSurg portfolio successful US acute attraction settings. While the transaction is expected to beryllium somewhat dilutive to adjusted EPS successful 2026, it is projected to go accretive starting successful 2027.
15 States with the Best Healthcare successful the US
Solventum Corporation (NYSE:SOLV) is simply a healthcare institution that develops, manufactures, and commercializes a portfolio of solutions to code captious lawsuit and diligent needs successful the US and internationally. It has 3 segments: Medsurg, Dental Solutions, and Health Information Systems.
While we admit the imaginable of SOLV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published at Insider Monkey.

1 month ago
14





English (CA) ·
English (US) ·
Spanish (MX) ·